Difficulty: Medium
Average Score: 77%
Practice
A 3-week-old male baby develops a rash involving the face and periorbital area after exposure to sunlight; you suspect neonatal lupus. The NEXT step of management of the baby is
Correct answer
A
Rationale
In this scenario, the correct next step in managing a 3-week-old baby with a rash suggestive of neonatal lupus after sun exposure is to measure anti-Ro antibodies (Option A). Neonatal lupus is often associated with the presence of maternal autoantibodies, particularly anti-Ro and anti-La antibodies. These antibodies can cross the placenta and affect the baby, leading to various manifestations including skin rashes.
Option A is correct because measuring anti-Ro antibodies can help confirm the diagnosis of neonatal lupus. Positive anti-Ro antibodies in the baby's blood would support the diagnosis and guide further management. This step is crucial as it can prompt appropriate interventions and monitoring for potential complications.
Options B, C, and D are incorrect in this context. Measuring anti-La antibodies (Option B) is less specific for neonatal lupus compared to anti-Ro antibodies. While neonatal lupus can be associated with cardiac manifestations (Option C), the initial presentation of a rash prompts the need for confirming the diagnosis through antibody testing before proceeding to cardiac evaluation. Hematological evaluation (Option D) is not indicated as the primary concern in this case is the skin rash and its association with neonatal lupus.
From an educational perspective, understanding the significance of maternal autoantibodies in neonatal lupus is crucial for pediatric nurses. Recognizing the importance of specific antibody testing in confirming the diagnosis and guiding management is essential for providing optimal care to infants with suspected neonatal lupus. This case underscores the need for a systematic approach to assessing and managing neonatal conditions, emphasizing the importance of appropriate diagnostic steps in clinical practice.
Option A is correct because measuring anti-Ro antibodies can help confirm the diagnosis of neonatal lupus. Positive anti-Ro antibodies in the baby's blood would support the diagnosis and guide further management. This step is crucial as it can prompt appropriate interventions and monitoring for potential complications.
Options B, C, and D are incorrect in this context. Measuring anti-La antibodies (Option B) is less specific for neonatal lupus compared to anti-Ro antibodies. While neonatal lupus can be associated with cardiac manifestations (Option C), the initial presentation of a rash prompts the need for confirming the diagnosis through antibody testing before proceeding to cardiac evaluation. Hematological evaluation (Option D) is not indicated as the primary concern in this case is the skin rash and its association with neonatal lupus.
From an educational perspective, understanding the significance of maternal autoantibodies in neonatal lupus is crucial for pediatric nurses. Recognizing the importance of specific antibody testing in confirming the diagnosis and guiding management is essential for providing optimal care to infants with suspected neonatal lupus. This case underscores the need for a systematic approach to assessing and managing neonatal conditions, emphasizing the importance of appropriate diagnostic steps in clinical practice.